is that through alternative splicing, PD-L1 can form a lncRNA molecule; this lncRNA was related to lung adenocarcinoma progression by enhancing c-Myc activity and justify deeper studies for investigating PD-L1-lnc depletion in combination with PD-L1 blockade in lung cancer therapy [75]. The gene discussed is CD274; the disease is lung carcinoma.